- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hormone-Refractory Prostate Cancer in United Kingdom
Total 6898 results
-
Burzynski Research InstituteTerminatedMetastatic Prostate CancerUnited States
-
AmgenTerminatedMetastatic Castration-resistant Prostate CancerUnited States, Sweden, Spain, United Kingdom, Australia, Denmark
-
VA Greater Los Angeles Healthcare SystemLantheus Medical ImagingNot yet recruiting
-
Lida JafariUniversity of California, Los AngelesUnknown
-
Thomas Jefferson UniversityNot yet recruitingMetastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8United States
-
Tavanta TherapeuticsCompletedMetastatic Prostate Cancer | Metastatic Castration-sensitive Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Spain, United Kingdom, Hungary, France, Poland, Puerto Rico, Sweden
-
Radboud University Medical CenterJohns Hopkins University; University Health Network, Toronto; Medical University... and other collaboratorsCompletedProstate CancerUnited States, Austria, Belgium, Canada, Germany, Netherlands, Norway, United Kingdom
-
Weill Medical College of Cornell UniversityMillennium Pharmaceuticals, Inc.CompletedNeuroendocrine Prostate Cancer | Small Cell Prostate Cancer | Prostate Adenocarcinoma Plus > 50% Immunohistochemical Staining for Neuroendocrine MarkersUnited States
-
University of California, San FranciscoCompletedMetastatic Prostate CancerUnited States
-
University of Michigan Rogel Cancer CenterExelixisTerminatedProstate Cancer MetastaticUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Stage I Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8United States
-
Wirral University Teaching Hospital NHS TrustNovartisCompleted
-
Mayo ClinicNational Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Prostate Carcinoma | Recurrent Prostate Carcinoma | Stage III Prostate Cancer | Stage IV Prostate CancerUnited States
-
Burzynski Research InstituteWithdrawnRecurrent Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Cambridge University Hospitals NHS Foundation TrustUniversity of Cambridge; Janssen-Cilag Ltd.Recruiting
-
Zin W MyintCompletedProstate Cancer | Prostate Adenocarcinoma | Prostate Cancer RecurrentUnited States
-
GenSpera, Inc.WithdrawnProstate Cancer.United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingStage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8United States
-
BayerActive, not recruitingBone Metastatic Castration-resistant Prostate CancerFrance, Lithuania, Israel, Italy, United Kingdom, Austria
-
Northwestern UniversityNorthShore University HealthSystemCompletedProstate CancerUnited States
-
Donald Trump, MDTerminated
-
Burzynski Research InstituteWithdrawnStage IV Prostate CancerUnited States
-
Temple UniversityCompleted
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingMetastatic Prostate Carcinoma | Prostate Adenocarcinoma | Recurrent Prostate Carcinoma | Hormone-Resistant Prostate CancerUnited States
-
National Cancer Institute (NCI)TerminatedAdenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Testosterone Greater Than 150 ng/dLUnited States
-
Hoffmann-La RocheTerminatedProstate CancerSpain, United Kingdom, France, Germany, Italy, Netherlands
-
National Cancer Institute (NCI)TerminatedRecurrent Prostate Cancer | Adenocarcinoma of the ProstateUnited States
-
University of California, San FranciscoMerck Sharp & Dohme LLCCompletedMetastatic Prostate Cancer | Castration Resistant Prostatic CancerUnited States
-
The Methodist Hospital Research InstituteRecruitingProstate Cancer | High-risk Prostate CancerUnited States
-
Dana-Farber Cancer InstituteMedivation, Inc.Completed
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedStage IV Prostate CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Johns Hopkins UniversityCompletedSuspected Primary Prostate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingProstate Cancer | Castration-resistant Prostate Cancer | Prostate Adenocarcinoma | Prostate Cancer Metastatic | Prostate NeoplasmUnited States
-
Daniel VaenaCompletedProstate Cancer | Castrate Resistant Prostate CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingCastration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Prostate Adenocarcinoma Without Neuroendocrine DifferentiationUnited States
-
Praful Ravi, MB BCHir, MRCPEli Lilly and Company; BayerActive, not recruitingProstate Cancer | Metastatic Prostate Cancer | Non-metastatic Prostate CancerUnited States
-
University of Wisconsin, MadisonProstate Cancer Foundation; Madison Vaccines, IncCompletedMetastatic Prostate Carcinoma | Prostate Adenocarcinoma | Metastatic Malignant Neoplasm in the Bone | Metastatic Malignant Neoplasm in the Soft Tissues | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
University of Rochester NCORP Research BaseNational Cancer Institute (NCI)RecruitingStage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8United States
-
University of FloridaCompleted
-
University of Alabama at BirminghamSanofi; Astellas Pharma IncWithdrawn
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedMetastatic Prostate CancerUnited States
-
Baylor College of MedicineCompletedLocalized Prostate CancerUnited States
-
University of Colorado, DenverCompletedProstate Cancer ScreeningUnited States
-
Lahey ClinicTerminated
-
University of ChicagoNorthShore University HealthSystemCompletedRecurrent Prostate Cancer | Bone Metastases | Stage IV Prostate Cancer | Castrate-resistant Prostate CancerUnited States
-
Institute of Cancer Research, United KingdomCancer Research UK; National Institute for Health Research, United KingdomRecruitingProstate Cancer | BRCA1 Mutation | BRCA2 MutationUnited Kingdom
-
Io TherapeuticsCompletedCastration Resistant Prostate CancerUnited States
-
Won KimNovartisTerminated
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Stage IV Prostate CancerUnited States